View Older Stories View More Recent Stories

Jan 25, 2021 09:00AM Usio Enters into Exclusive Contract with Leading Crypto Brokerage - Voyager Digital Holdings
Jan 14, 2021 08:00AM Voyager Digital Announces Listing Of The Elrond (EGLD) Gold Token
Jan 11, 2021 04:03PM Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 22, 2020 04:20PM Voyager (VYGR) announces FDA has notified Neurocrine (NBIX) that it has placed clinical hold on RESTORE-1 clinical trial of NBIb-1817
Dec 22, 2020 04:17PM Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
Nov 9, 2020 04:00PM Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
Oct 12, 2020 04:04PM Voyager Therapeutics (VYGR) Announces IND Submission for VY-HTT01 Program Was Placed on Clinical Hold
Oct 12, 2020 04:01PM Voyager Therapeutics Provides Regulatory Update on VY-HTT01 Program
Oct 1, 2020 04:01PM Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 15, 2020 04:02PM Voyager Therapeutics (VYGR) Announces Nancy Vitale to Board
Sep 15, 2020 04:01PM Voyager Therapeutics Appoints Nancy Vitale to its Board of Directors
Sep 14, 2020 04:30PM Voyager Therapeutics Appoints Michelle Quinn Smith as Chief Human Resources Officer
Sep 11, 2020 11:36AM Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor F
Sep 11, 2020 11:33AM Neurocrine Bio (NBIX), Voyager (VYGR) Present New L-T 3-Year Data Demonstrating that One-Time Treatment with Investigational Gene Therapy Showed Sustained Improvement in Motor Function
Sep 11, 2020 11:32AM Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor F
Sep 3, 2020 04:29PM Voyager Therapeutics Announces Upcoming Presentations at the International Parkinson and Movement Disorder Society Virtual Congress 2020
Aug 10, 2020 07:00AM Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
Aug 3, 2020 04:30PM Voyager Therapeutics to Report Second Quarter 2020 Financial Results and Participate in Upcoming Investor Conferences
Aug 3, 2020 04:01PM Voyager Therapeutics Provides Update on AbbVie Vectorized Antibody Collaborations
Jun 16, 2020 04:01PM Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 6, 2020 07:00AM Voyager Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
Apr 29, 2020 07:30AM Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2020 Annual Meeting
Apr 3, 2020 08:36AM Voyager Therapeutics (VYGR) Provides Update on RESTORE-1 Parkinson’s Disease Trial
Apr 3, 2020 08:30AM Voyager Therapeutics Provides Update on the RESTORE-1 Parkinson’s Disease Trial
Mar 9, 2020 08:00AM Voyager Therapeutics Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference
Mar 3, 2020 04:01PM Voyager Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates
Feb 26, 2020 05:00PM Voyager Therapeutics to Participate in Upcoming Investor Conferences
Feb 25, 2020 04:30PM Voyager Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 3, 2020
Nov 6, 2019 06:22AM Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights
Oct 31, 2019 08:00AM Voyager Therapeutics to Present at the Credit Suisse Healthcare Conference
Oct 30, 2019 04:35PM Voyager Therapeutics to Host Third Quarter 2019 Financial Results and Corporate Highlights Conference Call
Oct 28, 2019 02:00AM Voyager Digital Vastly Increases its Market by Releasing New Crypto Broker and Trading App for Android
Sep 25, 2019 08:00AM Voyager Therapeutics to Present at Upcoming Investor Conferences in October 2019
Aug 28, 2019 08:00AM Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019
Aug 9, 2019 07:00AM Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
Aug 5, 2019 04:30PM Voyager Therapeutics to Host Second Quarter 2019 Financial Results and Corporate Highlights Conference Call
Jul 30, 2019 04:30PM Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019
Jun 17, 2019 07:33AM Voyager Therapeutics (VYGR) Reports Restructured Gene Therapy Relationship with Sanofi (SNY) Genzyme; Provides Portfolio Update
Jun 17, 2019 07:30AM Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
Jun 11, 2019 04:30PM Voyager Therapeutics to Present at the Raymond James Life Sciences & MedTech Conference
May 20, 2019 04:33PM Voyager Therapeutics (VYGR) announces retirement of Dinah Sah, Ph.D. as chief scientific officer
May 20, 2019 04:30PM Voyager Therapeutics Announces Management Updates
May 7, 2019 07:05AM Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights
May 6, 2019 05:44AM Neurocrine Biosciences (NBIX), Voyager Therapeutics, Inc. (VYGR) Report Phase I Results for VY-AADC in Patients with Parkinson's Disease at AAN 2019 Meetings
May 5, 2019 09:05AM Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson's Disease at the American Academy of Neurology Annual Meeting
May 5, 2019 09:05AM Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting
Apr 29, 2019 07:04AM Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
Apr 15, 2019 12:25PM Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
Apr 3, 2019 04:15PM Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c)(4)
Apr 2, 2019 04:15PM Voyager Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
View More Recent Stories View Older Stories